Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.
Jeremy Nighohossian, PhD
Advertisement
Articles by Jeremy Nighohossian, PhD
Advertisement
Latest Updated Articles
Impact of Delayed Adoption of Novel Atrial Fibrillation TreatmentsDecember 11th 2024
Advertisement
Advertisement
Trending on AJMC
1
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
2
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
3
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
4
Tisagenlecleucel Yields Promising Disease-Free Survival in High-Risk Pediatric ALL: Shannon L. Maude, MD, PhD
5